Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-27

FDA Approved: LORAZEPAM — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for lorazepam from Aurolife Pharma LLC, enabling the commercialization of a generic Lorazepam product (ANDA 203572).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)